7
May
2024

Polpharma Group

Exhibitor at CPHI North America 2024 stand 814
About Us

Polpharma Group is a high quality European pharma manufacturer and a reputable business partner for pharmaceutical companies worldwide.
With its diversified products (Rx, CHC, APIs), professional services and competences at every stage of the value chain as well as deep knowledge of local markets in CEE/CIS it offers unique opportunities to the B2B partners to grow beyond the scale together. Polpharma Group can offer an excellent environment for collaboration, support from qualified experts and state-of-the-art equipment. Therefore, we are actively looking for partners in all of our activity areas – from product development stage, through production and commercial cooperation, to other forms of partnership.  

Polpharma API  
is a Poland-based CDMO of active pharmaceutical ingredients (APIs), and significant European API producer, delivering products to pharmaceutical companies worldwide. We run with $45-million manufacturing expansion to include HPAPI and cryogenic technologies and investments in a pilot plant and R&D capabilities. We expect to extend our operations starting from mid-2023 with full completion scheduled for 2026.
...

  • PL
  • 2015
    On CPHI since
  • 3
    Certificates
  • 5000+
    Employees
Company types
CMO/CDMO
Contract Service
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Contact info
Event information
CPHI North America 2024
  • 07 May 2024 - 09 May 2024
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 814

Products Featured at CPHI North America 2024

  • Ticagrelor

    Product Ticagrelor

    DISCLAIMER

    The above product is presented solely for informational purposes and does not constitute an offer in any sense. Products with PIPELINE & EARLY DEVELOPMENT STATUS under patent (SPC) protection in Poland and/or other countries are not offered until expiration of the corresponding IP...
  • Baclofen

    Product Baclofen

    Therapeutical Area: Musculo-skeletal system • EU DMF available • US DMF no. 18014 available • Japanese DMF available • CEP available
    Indication: Baclofen is primarily used for the treatment of spastic movement disorders and alcoholism.





  • Risedronate sodium

    Product Risedronate sodium

    Therapeutic Area: Musculo-skeletal system • EU DMF available • US DMF no. 20384 available • Japanese DMF available • CEP available

    Indication: Risedronate sodium is a pyridinyl bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism.


  • Hydrochlorothiazide

    Product Hydrochlorothiazide

    Therapeutic Area: Cardiovascular system • EU DMF available • US DMF no. 17599 available • Japanese DMF available  • CEP available

    Indication: Hydrochlorothiazide is a diuretic drug of the thiazide class that acts by inhibiting the kidneys' ability to retain water. This reduces the volum...
  • Tadalafil

    Product Tadalafil

    Therapeutic area: genito-urinary system & sex hormones

    EU DMF available

    US DMF : 24590

    CEP available

  • Alendronate sodium

    Product Alendronate sodium

    Therapeutic Area: Musculo-skeletal system • EU DMF available • US DMF no. 16962 available • Japanese DMF available • CEP available

    Indication: Alendronate sodium is a bisphosphonate drug used for osteoporosis and several other bone diseasesMusculo-skeletal diseases

  • Acenocoumarol

    Product Acenocoumarol

    Therapeutic Area: Cardiovascular systemEU DMF available Indication: Acenocoumarol is an anticoagulant that functions as a vitamin K antagonist
  • Acetazolamide

    Product Acetazolamide

    Therapeutic Area: Cardiovascular system • EU DMF available • US DMF no. 10383 available • CEP available Available also in injectable form
    Indication: Acetazolamide decreases the pressure in the eye and is used for adjunctive treatment of glaucoma, a condition in which increased pressure ...
  • Aripiprazole

    Product Aripiprazole

    Therapeutic Area: Nervous System • EU DMF available • US DMF no. 23314 available • CEP available

    Indication: used to treat the symptoms of psychotic conditions such as schizophrenia and bipolar disorder (manic depression). It is also used together with other medications to treat major depr...
  • Carbamazepine

    Product Carbamazepine

    Therapeutic Area: Nervous System
    • EU DMF available • US DMF no. 26266 available • CEP available Indication: Carbamazepine is an anticonvulsant and mood-stabilizing drug used primarily in the treatment of epilepsy and bipolar disorder, as well as trigeminal neuralgia.


  • Carvedilol

    Product Carvedilol

    Therapeutic Area: Cardiovascular system • EU DMF available • US DMF no. 17060 available • CEP available
    Indication: Carvedilol is a carbazole derivative acts as anti-hypertensive agent. It is formulated as tablets for oral route of administration. Carvedilol is indicated for the management of e...
  • Clopamide

    Product Clopamide

    Therapeutic Area: Cardiovascular system • EU DMF available
    Indication: Clopamide is indicated for the treatment of oedema, hypertension. It is formulated as tablet for oral administration. It is categorised as a thiazide like drug and works in similar way as the thiazide diuretics. It acts at the p...
  • Carvedilol phosphate hemihydrate

    Product Carvedilol phosphate hemihydrate

    Therapeutic area: Cardiovascular system • EU DMF available • US DMF no. 20633 available 
  • Etodolac

    Product Etodolac

    Therapeutic Area: Musculo-skeletal system • EU DMF available • US DMF no. 11405 available • Japanese DMF available • CEP available

    Indication: Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) used for the management of mild to moderate pain, fever, and inflammation.


  • Ibandronate Sodium

    Product Ibandronate Sodium

    Therapeutic Area: Musculo-skeletal system • EU DMF available • US DMF no. 25638 available • Chinese DMF - under registration

    Indication: Ibradronic Sodium is a potent bisphosphonate drug used in the prevention and treatment of osteoporosis